期刊文献+

TNF-α单克隆抗体治疗大鼠肝肺综合征的机制研究 被引量:2

Therapeutic mechanisms of tumor necrosis factor-α monoclonal antibody on hepatopulmonary syndrome in rats
暂未订购
导出
摘要 目的:探讨肿瘤坏死因子-α抗体(TNF-α-McAb)抑制肝肺综合征大鼠TNF-α作用后肺组织诱导型一氧化氮合酶(iNOS)的表达情况,从而探讨TNF-α单克隆抗体对肝肺综合症治疗作用的机制。方法:采用胆总管结扎(CBDL)致大鼠肝肺综合征模型,将60只雄性SD大鼠随机分成假手术组、模型组和TNF-α-McAb干预组。采用HE染色观察肺组织病理变化,采用RT-PCR方法检测iNOS在肺组织中mRNA表达水平,免疫组织化学方法检测iNOS在肺组织中分布及含量的动态变化,采用Western blotting方法检测iNOS在肺组织中蛋白表达情况。结果:肺组织病理显示干预组病理改变炎症反应较模型组轻,TNF-α-McAb干预组大鼠肺组织中iNOS mRNA的表达、蛋白含量明显低于模型组。结论:肿瘤坏死因子-α单克隆抗体通过抑制iNOS的表达对肝肺综合征起到治疗作用。 AIM : To investigate the expression of iNOS in the lung of HPS rats treated with tumor necrosis factor -α monoclonal antibody ( TNF -α - McAb) and to investigate the therapeutic mechanism of TNF -α - McAb on hepatopulmonary syndrome. METHODS: Male Sprague -Dawley rats, weighing (250 ±25)g, were randomized to sham operation group, common bile duct ligation (CBDL) group and CBDL + TNF -α McAb treatment group. Histopathological changes of the lung tissue were evaluated by hematoxylin and eosin staining. The mRNA expression of iNOS in the lungs of hepatopulmonary rats was examined by RT - PCR, while the changes of iNOS in the protein level were evaluated by immunohistochemistry and Western blotting. RESULTS : The inflammatory responses in the CBDL rats treated with TNF -α - McAb decreased than that in CBDL group. Compared to CBDL group, the distribution of iNOS protein and the mRNA expressions in the lung tissue in TNF -α - McAb group were inhibited. CONCLUSION: TNF - α- McAb inhibits the expression of iNOS and plays a role in the treatment of HPS.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2010年第6期1138-1141,共4页 Chinese Journal of Pathophysiology
基金 河北省医学科学研究重点资助课题(No.08080)
关键词 肿瘤坏死因子-α单克隆抗体 肿瘤坏死因子 诱导型一氧化氮合酶 肝肺综合征 Tumor necrosis factor -α monoclonal antibody Tumor necrosis factor Inducible nitric oxide synthase Hepatopulmonary syndrome
  • 相关文献

参考文献8

  • 1Vercelino R,Tieppo J,Forgiarini Junior LA,et al.Experimental models for assessment of pulmonary alterations in hepatopulmonary syndrome[J].J Bras Pneumol,2008,34(7):453-460.
  • 2Zhang J,Ling Y,Tang L,et al.Attenuation of experimental hepatopulmonary syndrome in endothelin B receptor-deficient rats[J].Am J Physiol Gastrointest Liver Physiol,2009,296(4):G704-G708.
  • 3Schroeder RA,Ewing CA,Sitzmann JV,et al.Pulmonary expression of iNOS and HO-1 protein is upregulated in rat model of prehepatic portal hypertension[J].Dig Dis Sci,2000,45(12):2405-2410.
  • 4Nunes H,Lebrec D,Macmanian M,et al.Role of nitric oxide in hepatopulmonary syndrome in cirrhotic rats[J].Am J Respir Crit Care Med,2001,164(5):879-885.
  • 5Zhang J,Ling Y,Luo B,et al.Analysis of pulmonary heme oxygenase-1 and nitric oxide synthase alterations in experimental hepatopulmonary syndrome[J].Gastroenterology,2003,125 (5):1441-1451.
  • 6孙海燕,杨明功.NO、NOS、NOS基因与糖尿病微血管并发症[J].国外医学(内分泌学分册),2001,21(3):136-139. 被引量:9
  • 7Rabiller A,Nunes H,Lebrec D,et al.Prevention of gram-negative translocation reduces the severity of hepatopulmonary syndrome[J].Am J Respir Crit Care Med,2002,166(4):514-517.
  • 8万云乐,吴丽花,余松峰,金晶,柯庆宏,郑树森.丙氨酰-谷氨酰胺下调口服他克莫司损伤的肠黏膜组织中iNOS和TNF-α的表达(英文)[J].中国病理生理杂志,2007,23(5):939-944. 被引量:5

二级参考文献35

  • 1Wischmeyer PE,Riehm J,Singleton KD,et al.Glutamine attenuates tumor necrosis factor-alpha release and enhances heat shock protein 72 in human peripheral blood mononuclear cells[J].Nutrition,2003,19(1):1 -6.
  • 2Basivireddy J,Jacob M,Balasubramanian KA.Oral glutamine attenuates indomethacin-induced small intestinal damage[J].Clin Sci (Lond),2004,107(3):281 -289.
  • 3Whittle BJ.Nitric oxide and the gut injury induced by non-steroidal anti-inflammatory drugs[J].Inflammopharmacology,2003,11(4):415 -422.
  • 4Dumont FJ.FK506,an immunosuppressant targeting calcineurin function[J].Curr Med Chem,2000,7 (7):731-748.
  • 5Escribano O,Fernandez-Moreno MD,Pina MJ,et al.Pretreatment with FK506 up-regulates insulin receptors in regenerating rat liver[J].Hepatology,2002,36 (3):555-561.
  • 6Christians U,Jacobsen W,Benet LZ,et al.Mechanisms of clinically relevant drug interactions associated with tacrolimus[J].Clin Pharmacokinet,2002,41 (11):813-851.
  • 7Asano T,Nishimoto K,Hayakawa M.Increased tacrolimus trough levels in association with severe diarrhea,a case report[J].Transplant Proc,2004,36(7):2096 -2097.
  • 8Yagi M,Sakamoto K,Hasebe K,et al.Effect of a glutamine-enriched diet on small bowel allograft during immunosuppressive therapy[J].Nutrition,1997,13 (9):778-782.
  • 9Madsen KL,Yanchar NL,Sigalet DL,et al.FK506 increases permeability in rat intestine by inhibiting mitochondrial function[J].Gastroenterology,1995,109(1):107-114.
  • 10Wang M,Kubodera S,Araki I,et al.Inhibition of nitric oxide synthase induces intestinal mucosal damage and increases mortality in rats treated by FK506[J].Exp Toxicol Pathol,2001,53(4):297-301.

共引文献12

同被引文献11

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部